Ara
Toplam kayıt 247, listelenen: 1-10
Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study
(Elsevier B.V., 2022)
Objective: Although the age at diagnosis has been suggested as a major determinant of disease-specific survival in the recent TNM staging system, it is not included in the recent American Thyroid Association (ATA) guidelines ...
Development and validation of the gaming disorder scale-family form
(Slack Incorporated, 2021)
The aim of the current methodological study was to develop a psychometric measurement tool for determining internet gaming disorder (IGD) based on family members’ responses. The sample comprised 173 adolescents and their ...
Rare malacoplakia of the prostate: presentation with three cases
(Springer, 2021)
[No Abstract Available]
The effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients (Meeting Abstract)
(Wiley, 2020)
[No Abstract Available]
Molecular profiles of screen-detected breast cancers from a Turkish breast cancer screening program
(Lippincott Williams & Wilkins, 2013)
[No Abstract Available]
Hypoplastic internal carotid artery ending as an ophthalmic artery with multiple cerebral aneurysms, fenestrated Acom and triple A2
(BMJ Publishing Group, 2021)
A rare case of a hypoplastic internal carotid artery (ICA) terminating in the ophthalmic artery with multiple intracranial saccular aneurysms in the contralateral ICA, anterior communicating artery fenestration and triple ...
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
(Elsevier Inc., 2022)
Introduction/Background: The emergence of novel agents targeting the B-cell receptor pathway and BCL-2 has significantly changed the therapeutic landscape of CLL. We evaluated the safety and efficacy of single-agent ibrutinib ...
Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure Database
(NLM (Medline), 2022)
OBJECTIVE: Because of concerns about malignancy risks, using biological disease-modifying antirheumatic drugs (bDMARDs) in patients with a history of malignancy remains a challenging issue in rheumatology practice. This ...
Comparison of Multiple Sclerosis Patients Using First Line Treatment vs Second Line Treatment
(Sage Publications Ltd, 2020)
[No Abstract Available]
Comparison of VEP Parameters in NMOSD and MS Patients
(Sage Publications Ltd, 2019)
[No Abstract Available]